OMECARDIO trial: a randomized, double-blind, placebo-controlled study on the impact of omega-3 on inflammageing biomarkers and vascular stiffness in hypertensive and dyslipidemic patients
                              
 
                                  Event:
                                  
                                    ESC Congress 2025
                                  
 
                                  Topic:
                                  
                                    Pharmacotherapy
                                  
 
                                  Session:
                                  
                                    Inflammation, immunity, and fibrosis